Literature DB >> 21918503

Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm.

Andrés Uribe-Mariño1, Audrey Francisco, Maria Angélica Castiblanco-Urbina, André Twardowschy, Carlos José Salgado-Rohner, José Alexandre S Crippa, Jaime Eduardo Cecílio Hallak, Antônio Waldo Zuardi, Norberto Cysne Coimbra.   

Abstract

Several pharmacological targets have been proposed as modulators of panic-like reactions. However, interest should be given to other potential therapeutic neurochemical agents. Recent attention has been given to the potential anxiolytic properties of cannabidiol, because of its complex actions on the endocannabinoid system together with its effects on other neurotransmitter systems. The aim of this study was to investigate the effects of cannabidiol on innate fear-related behaviors evoked by a prey vs predator paradigm. Male Swiss mice were submitted to habituation in an arena containing a burrow and subsequently pre-treated with intraperitoneal administrations of vehicle or cannabidiol. A constrictor snake was placed inside the arena, and defensive and non-defensive behaviors were recorded. Cannabidiol caused a clear anti-aversive effect, decreasing explosive escape and defensive immobility behaviors outside and inside the burrow. These results show that cannabidiol modulates defensive behaviors evoked by the presence of threatening stimuli, even in a potentially safe environment following a fear response, suggesting a panicolytic effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918503      PMCID: PMC3242302          DOI: 10.1038/npp.2011.188

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  52 in total

Review 1.  Neuroanatomical hypothesis of panic disorder, revised.

Authors:  J M Gorman; J M Kent; G M Sullivan; J D Coplan
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

Review 2.  Endocannabinoids in the central nervous system: from neuronal networks to behavior.

Authors:  Ester Fride
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-12

Review 3.  [Functional role of the endocannabinoid system in emotional homeostasis].

Authors:  E M Marco; M P Viveros
Journal:  Rev Neurol       Date:  2009 Jan 1-15       Impact factor: 0.870

Review 4.  Predator-elicited flight responses in Swiss-Webster mice: an experimental model of panic attacks.

Authors:  G Griebel; D C Blanchard; R J Blanchard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1996-02       Impact factor: 5.067

Review 5.  Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Jian-Ping Gong; Sejal Patel; Alex Perchuk; Paul A Meozzi; Lester Myers; Zoila Mora; Patricia Tagliaferro; Eileen Gardner; Alicia Brusco; Babatunde E Akinshola; Qing-Rong Liu; Bruce Hope; Shinya Iwasaki; Tadao Arinami; Lindsey Teasenfitz; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

6.  When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans.

Authors:  Dean Mobbs; Predrag Petrovic; Jennifer L Marchant; Demis Hassabis; Nikolaus Weiskopf; Ben Seymour; Raymond J Dolan; Christopher D Frith
Journal:  Science       Date:  2007-08-24       Impact factor: 47.728

7.  Cellular prion protein modulates defensive attention and innate fear-induced behaviour evoked in transgenic mice submitted to an agonistic encounter with the tropical coral snake Oxyrhopus guibei.

Authors:  Bruno Lobão-Soares; Roger Walz; Rui Daniel Schröder Prediger; Renato Leonardo Freitas; Fabrício Calvo; Marino Muxfeldt Bianchin; João Pereira Leite; Michele Christine Landemberger; Norberto Cysne Coimbra
Journal:  Behav Brain Res       Date:  2008-06-11       Impact factor: 3.332

8.  Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Authors:  Paolo Fusar-Poli; José A Crippa; Sagnik Bhattacharyya; Stefan J Borgwardt; Paul Allen; Rocio Martin-Santos; Marc Seal; Simon A Surguladze; Colin O'Carrol; Zerrin Atakan; Antonio W Zuardi; Philip K McGuire
Journal:  Arch Gen Psychiatry       Date:  2009-01

Review 9.  Benzodiazepine and serotonergic modulation of antipredator and conspecific defense.

Authors:  D C Blanchard; G Griebel; R J Rodgers; R J Blanchard
Journal:  Neurosci Biobehav Rev       Date:  1998-09       Impact factor: 8.989

10.  Antiaversive effects of cannabinoids: is the periaqueductal gray involved?

Authors:  F A Moreira; D C Aguiar; A C Campos; S F Lisboa; A L Terzian; L B Resstel; F S Guimarães
Journal:  Neural Plast       Date:  2008-12-02       Impact factor: 3.599

View more
  14 in total

Review 1.  Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.

Authors:  Jonathan L C Lee; Leandro J Bertoglio; Francisco S Guimarães; Carl W Stevenson
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

2.  Opposing roles of dorsomedial hypothalamic CB1 and TRPV1 receptors in anandamide signaling during the panic-like response elicited in mice by Brazilian rainbow Boidae snakes.

Authors:  Tayllon Dos Anjos-Garcia; Norberto Cysne Coimbra
Journal:  Psychopharmacology (Berl)       Date:  2019-01-29       Impact factor: 4.530

3.  Augmented anandamide signalling in the substantia nigra pars reticulata mediates panicolytic-like effects in mice confronted by Crotalus durissus terrificus pit vipers.

Authors:  Rafael C Almada; Luiz Luciano Falconi-Sobrinho; Juliana A da Silva; Carsten T Wotjak; Norberto C Coimbra
Journal:  Psychopharmacology (Berl)       Date:  2022-06-02       Impact factor: 4.415

4.  Imbalance of flight-freeze responses and their cellular correlates in the Nlgn3-/y rat model of autism.

Authors:  Natasha J Anstey; Vijayakumar Kapgal; Emma R Wood; Oliver Hardt; Peter C Kind; Shashank Tiwari; Thomas C Watson; Anna K H Toft; Owen R Dando; Felicity H Inkpen; Paul S Baxter; Zrinko Kozić; Adam D Jackson; Xin He; Mohammad Sarfaraz Nawaz; Aiman Kayenaat; Aditi Bhattacharya; David J A Wyllie; Sumantra Chattarji
Journal:  Mol Autism       Date:  2022-07-18       Impact factor: 6.476

Review 5.  Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.

Authors:  Alline Cristina Campos; Fabricio Araújo Moreira; Felipe Villela Gomes; Elaine Aparecida Del Bel; Francisco Silveira Guimarães
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 6.  Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.

Authors:  Yasmin L Hurd; Michelle Yoon; Alex F Manini; Stephanie Hernandez; Ruben Olmedo; Maria Ostman; Didier Jutras-Aswad
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 7.  Cannabidiol as a Potential Treatment for Anxiety Disorders.

Authors:  Esther M Blessing; Maria M Steenkamp; Jorge Manzanares; Charles R Marmar
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

8.  Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus.

Authors:  Asmat Ullah Khan; Luiz Luciano Falconi-Sobrinho; Tayllon Dos Anjos-Garcia; Maria de Fátima Dos Santos Sampaio; José Alexandre de Souza Crippa; Leda Menescal-de-Oliveira; Norberto Cysne Coimbra
Journal:  Psychopharmacology (Berl)       Date:  2020-01-09       Impact factor: 4.530

9.  Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge.

Authors:  Christopher J Barnum; Thaddeus W W Pace; Fang Hu; Gretchen N Neigh; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2012-01-16       Impact factor: 8.322

Review 10.  Evidences for the Anti-panic Actions of Cannabidiol.

Authors:  Vanessa P Soares; Alline C Campos
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.